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Conventional inclusion criteria used in osteoarthritis clinical trials are not very effective in selecting 
patients who would benefit from a therapy being tested. Typically majority of selected patients show no 
or limited disease progression during a trial period. As a consequence, the effect of the tested treatment 
cannot be observed, and the efforts and resources invested in running the trial are not rewarded. This 
could be avoided, if selection criteria were more predictive of the future disease progression. In this 
article, we formulated the patient selection problem as a multi-class classification task, with classes 
based on clinically relevant measures of progression (over a time scale typical for clinical trials). Using 
data from two long-term knee osteoarthritis studies OAI and CHECK, we tested multiple algorithms 
and learning process configurations (including multi-classifier approaches, cost-sensitive learning, 
and feature selection), to identify the best performing machine learning models. We examined the 
behaviour of the best models, with respect to prediction errors and the impact of used features, to 
confirm their clinical relevance. We found that the model-based selection outperforms the conventional 
inclusion criteria, reducing by 20–25% the number of patients who show no progression. This result 
might lead to more efficient clinical trials.
Knee osteoarthritis (OA) is a chronic degenerative joint disease characterised by cartilage loss and changes in 
bones underneath it, causing pain and functional disability. The main clinical symptoms of knee OA are pain and 
stiffness, particularly after activity1, leading to reduced mobility and quality of life, and eventually resulting in 
knee replacement surgery. OA is one of the leading causes of global disability in people aged 65 and older, and its 
burden is likely to increase in the future with the ageing of the population and rise in obesity worldwide2.
OA is a heterogeneous disease where progression spreads over several years with periods of fast changes and 
periods of stability3. A major challenge in OA drug development is effective selection of patients to the clinical 
trials. In an ideal case, all selected patients would show disease progression within the trial period, and their 
response to the drug in trial would be properly assessed. However, identification of patients in need of treatment, 
that is those with a high probability of progression, is an open problem.
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To help analyse knee OA progression, the APPROACH consortium (a partnership of over 20 European clin-
ical centres, research institutes, small enterprises and pharmaceutical companies) is running a 2-year obser-
vational study in 5 clinical centres from 4 European countries. One of the study objectives is to discover new 
markers of disease progression. The consortium recruits patients from centres with existing OA cohorts, and 
similarly to clinical trials, is interested in selecting only patients who will progress during the observation period.
The traditional approach to patient selection relies on expert knowledge and typically follows a set of con-
sensus criteria defined by the American College of Rheumatology (ACR), mixed with a presence of limited joint 
damage (so further progression is possible) and significant pain complaints. When these criteria are satisfied, the 
patient’s disease is expected to progress over time. However, the speed with which this will happen is unknown. 
This is a problem for clinical trials and short-term studies, like APPROACH, in which the observation time is 
typically limited to about 2 years.
The main hypothesis of this article is that machine learning can be more effective at identifying progressive 
patients than the traditional approach. We hypothesise that prediction models trained on historical data will be 
able to differentiate between patients for whom a fast progression happen during the observation period, and 
patients who show no progression or progress slowly and should not be selected to trials. Throughout the course 
of this article we examine different algorithms and learning process configurations, to finally develop predictive 
models for patient selection that outperform the conventional inclusion criteria used in clinical trials.
To train the models, and verify our hypothesis, we use longitudinal data from two large studies running in 
parallel in Europe and North America: the Cohort Hip and Cohort Knee (CHECK) study4, and the Osteoarthritis 
Initiative (OAI) study5. We outline a data preprocessing strategy to handle missing values and different attribute 
types, and we define four classes of patients using clinically relevant measures of OA progression. We set up the 
experiments that allow us to estimate the typical performance of a model on out-of-sample instances and find the 
best approach to handle the class imbalance present in the data. We choose the best performing algorithm and 
test several of its multi-model/multi-label variants to further improve performance. We select the most effective 
configuration of parameters and train the final models on all data and estimate their performance. Then we 
interpret the behaviour of these models, by looking at the individual features contribution to the model output, 
and assess their clinical relevance. Next, we simulate two patient selection scenarios and compare the best model 
results against the selection with conventional clinical classification criteria. Finally, we include a discussion on 
limitations, the experiment design choices, related literature, and future work.
Materials and methods
Datasets. The CHECK cohort data used in this article were contributed by the CHECK steering committee 
(available upon request at http://check-onderzoek.nl/). Specifically, we used the clinical and X-ray image assess-
ment (radiographic scoring and KIDA features6) data.
The OAI cohort data used in the preparation of this article were obtained from the Osteoarthritis 
Initiative (available at http://www.oai.ucsf.edu/). Specifically, we used the clinical, X-ray image assessment 
(semi-quantitative readings and joint space width measurements) and outcomes (knee replacements) data.
Both of these cohorts have been studied for over 10 years, and collected longitudinal data with typically yearly 
updates. For both cohorts we used the time points between the study baseline and the 8 year follow-up, for which 
the joint space width measurements (used in class definition) were available (see summary in Table 1). To maxim-
ise the size of the training set, instead of using only the baseline and 2 year follow-up time points, for every patient 
we used all available periods that were at least 2-year long (some periods were longer than two years, e.g. between 
CHECK time points 2–5 or 5–8). As a consequence, each instance in the training set represented a period, not a 
patient. We excluded all periods after a knee replacement, to avoid problems with a change in meaning of some 
attributes (e.g. pain would no longer be related to the knee but to issues with the prosthesis).
As we show in tab:datasets, both datasets contain a relatively large number of attributes and a small number of 
patients, together with a large proportion of missing values. This introduces a challenge to the machine learning 
algorithms and we tried to improve this balance with additional preprocessing steps (see below).
Preprocessing. We dropped all attributes with more than 50% missing values and all periods with over 40% 
missing attributes. These thresholds are quite conservative, as we tried to retain as much data as possible. We also 
dropped all attributes that did not vary across instances (i.e. had just a single non-null value), and thus were not 
useful in distinguishing between the classes. Finally, we removed attributes that could be exploited by the model, 
such as dates, visit numbers, barcodes and patient and staff IDs.
As the CHECK cohort is one of the recruitment sources for the APPROACH consortium, we spent extra time 
analysing the reasons behind the missing values and fixing them were possible. We filled forward values from the 
most recent time point, for attributes which values cannot change in the future (e.g. past diseases), and used a 
default value in place of a missing one where this was a reporting convention (e.g. for presence of rare disorders).
patients periods attributes
used 
timepoints
missing 
values
CHECK 1 002 3 001 513 0,2,5,8 34%
OAI 3 465 16 800 1 536 0,1,2,3,4,6,8 59%
Table 1. Summary of the main characteristics of the datasets used in this work.
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For both datasets, we assumed that all attributes with at most 10 different values are categorical. For CHECK, 
we additionally went through the cohort variable guide and manually identified ordinal and continuous attrib-
utes. This step was not practical for OAI, as its variable guide has almost 4000 pages.
We performed additional preprocessing during the model training. We imputed missing values, using only the 
values found in the training set (to avoid information leaks from the test set). We performed the imputation with 
the mode/mean value (for categorical/continuous attributes). We briefly tried other methods (cluster centroids, a 
vote of nearest neighbours), but as they did not produce better results, we settled for the simplest method.
The final step after imputation was the one-hot encoding of nominal attributes. That is, their replacement with 
dummy attributes, of which only one is “hot” at a time (set to 1, while others are zero). We encoded all categorical 
attributes with more than 2 distinct values, unless they were known to be ordinal.
Class definition. The APPROACH consortium decided to use similar patient categorisation to the OAI-based 
FNIH biomarker study7, but defined more broadly and bounded in the observation time to 2 years. Patients were 
split into one non-progressive category (N), and three progressive categories related to pain (P), structure (S), and 
combined pain and structure (P + S).
To define the categories, the consortium relied on the measures of pain symptoms and structural damage 
at the beginning and at the end of a period. Pain was measured using the pain subscale from the WOMAC 
self-report questionnaire8, which includes perceived level of pain during 5 different activities: walking, using 
stairs, in bed, sitting or lying, and standing upright. Structural progression was measured using radiographic 
readings of minimum joint space width (JSW) across both lateral and medial femorotibial compartments of the 
knee.
The exact definitions of the categories are given below:
•	 S period — a minimum total JSW must decrease by at least 0.3 mm per year,
•	 P period — patient must experience progressive or intense sustained pain (Eq. 1):
•	 pain increase of at least 5 WOMAC points per year ( p 5∆ ≥ ) on 0–100 scale,
•	 pain at the end of a period (pe) must be substantial (p 40e ≥ ),
•	 for a rapid pain increase (∆ ≥p 10), end pain can be lower (p 35e ≥ ),
•	 sustained pain must be substantial at both the start (ps) and the end (pe) of a period (p p40 40s e∩≥ ≥ ).
p p p p p p(( 5 40) ( 10 35)) ( 40 40) (1)e e s e∩ ∪ ∩ ∪ ∩∆ ≥ ≥ ∆ ≥ ≥ ≥ ≥
For each period, the most affected knee (with greater JSW narrowing) and maximum pain (if reported for 
both knees) were used in the calculation of progression. When we could not measure the progression due to miss-
ing values, we excluded the period. This way, the class definition was never based on imputed numbers.
We assigned a period to the P + S category when criteria for both P and S were satisfied, and to the remain-
ing N category if none were satisfied. We obtained imbalanced class distributions strongly skewed towards the 
non-progressive periods (see Table 2).
Experimental setup. All experiments were performed using the scikit-learn library9 and its imple-
mentation of the machine learning algorithms. In data preprocessing, analysis and generation of statistics, we 
used pandas10, NumPy11 and SciPy12. For data visualisation, we used seaborn13 and Matplotlib14.
Measure of performance. To measure the classification performance we used the F1 score15. It is commonly used 
in information retrieval, where relevant documents have to be identified amongst a large number of unrelated 
ones, and therefore is well suited for patient selection. F1 score is defined as a harmonic mean of precision and 
recall, where precision is the probability that a (randomly selected) retrieved document is relevant, and recall is the 
probability that a (randomly selected) relevant document has been retrieved. In medical literature precision is 
known as positive predictive value and recall is equivalent to sensitivity.
Although F1 score has been originally designed for binary classification, it can be extended to a multi-class case 
by averaging the F1 scores across classes. Throughout this article we use weighted average of per class F1 scores, 
with weights depending on the class instance frequency (to take into account the class imbalance).
Cross-validation. In all experiments we used out-of-sample estimation of the algorithm performance. That is, we 
kept some of the instances hidden from the algorithm during training, and used them later as an independent test 
set. Specifically, we followed the standard 10-fold stratified cross-validation (CV) protocol, in which the instances 
are split into 10 approximately equal-sized parts (folds) and the split preserves the overall class distribution within 
each fold. Each fold is then used in turn as a test set, and the remaining 9 folds are used as a training set. To score 
the method performance, rather than averaging the scores across all 10 folds, we pool the out-of-sample predic-
tions together and use it to calculate a single score.
N P S P+S
CHECK 63% (1891) 12% (358) 20% (592) 5% (160)
OAI 74% (12502) 6% (953) 16% (2719) 4% (626)
Table 2. Balance between the classes for each dataset. Exact number of periods per class is given in brackets.
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The cross-validation is repeated 10 times with different partitions into folds. As some of the machine learning 
algorithms are not deterministic, we also repeat the model training (25 times) with different random seeds (the 
seeds remain constant across folds and cross-validation repeats). We report typical performance of a configura-
tion (algorithm + parameters), as a median score amongst the cross-validation repeats, where the score for each 
repeat is the median across all trained models.
Initial experiments. To test how well different machine learning algorithms can learn from the data, we initially 
simplified the problem to a case of balanced classification through down-sampling. We fixed the size of the classes 
to 150 for CHECK and 600 for OAI, and drew 11 different random samples of 600/2400 instances. For each sam-
ple we performed repeated cross-validation (as described in the previous section) using for each fold a fixed-size 
test set, and a subset of the training set of increasing size (10%, 20%, 100%), to obtain a learning curve.
We tested six machine learning algorithms with the default parameters:
•	 logistic regression16 (using one-vs-rest scheme),
•	 multinomial logistic regression using cross-entropy loss with L-BFGS solver,
•	 k nearest neighbours classifier (kNN17) using KD tree (default k 5= ),
•	 support vector classifier (SVC18) using one-vs-rest scheme with linear kernel,
•	 support vector classifier using one-vs-rest scheme with the Radial Basis Function (RBF) kernel (default 
C gamma1 0,
num features
1
_
= . = ),
•	 random forest19 (with 100 trees (default in scikit-learn 0.22)).
For scale-sensitive algorithms (SVC and kNN) all attribute values in the training set were scaled to the [0, 1] 
range.
In these initial experiments, random forest (see Results was the best performing algorithm (in line with litera-
ture20,21), and we focused our further experiments on it.
Cost-sensitive learning. Random forest can be made cost-sensitive by incorporation of class weights to penalise 
the misclassification of the minority classes (as the weights influence the node split criteria). The cost-sensitive 
learning is an alternative to up/down sampling techniques that does not introduce artificial instances (as with 
up-sampling of the minority classes) and does not lose information (as with down-sampling of the majority 
classes). And specifically for random forest, the algorithm creators have demonstrated that the weighted variant 
performs better on imbalanced data, than on up/down-sampled ones22.
To test the difference in performance between the cost-sensitive and the balanced learning, we first performed 
a repeated cross-validation (as before) using a full imbalanced dataset while incrementally increasing the training 
set size. Then we kept the imbalanced test sets unchanged, and down-sampled each of the imbalanced folds used 
to form the training set, to obtain a balanced training set that does not overlap with the imbalanced test set. We 
repeated this procedure 11 times with different sampling seeds. In the cost sensitive variant, we used weights 
inversely proportional to the class distribution in the full dataset.
The rationale behind this process is that regardless of the different training sets, the test sets have to remain the 
same in all cross-validation rounds, so that the performance scores obtained by the two strategies are truly com-
parable. With experiments set up this way, we are able to examine whether a larger training set is more important 
to performance than the class balance.
Multi-model methods. As we are trying to solve a multi-class problem, where the class labels are a combination 
of two clinical criteria (see Class definition), we have tested multi-model and multi-label strategies to further 
improve the performance of random forest. In particular, we first tested (1) a one-vs-rest scheme, in which a 
combination of 4 independent models is used, each trained to discriminate one class from the rest, and (2) a 
multi-label classification23, in which a single model is trained to assign P and S labels independently (rather than 
to predict the class) that are later mapped to 4 classes. Finally, we combined the two strategies to create (3) a duo 
classifier that uses two independent models, each trained to predict a single label (P or S). We implemented this 
classifier as a wrapper class on top of the random forest algorithm that predicts one of the 4 class labels, but at the 
same time, provides independent P and S probabilities for each instance.
Parameter tuning. To tune the configuration of the duo classifier we exhaustively searched the space of 84 com-
binations of three key random forest parameters in the following range:
•	 number of trees ∈[100, 200, 400, 600, 800, 1000],
•	 maximum tree depth ∈[4, 5, 6, 7, 8, 9, 10],
•	 split quality criterion gini entropy[ , ]∈  — (standing for Gini impurity and information gain).
Because we tried multiple models, cross-validated performance of the best configuration is an optimistically 
biased estimate of the performance of the final model trained on all data. This “multiple induction” problem is 
conceptually equivalent to multiple hypothesis testing in statistics. To estimate the unbiased performance of the 
final model, we used a recently proposed bootstrap-based BBC-CV protocol24. It is a computationally efficient 
alternative to the popular nested cross-validation procedure and provides good bias estimation for datasets with 
100+ instances.
BBC-CV uses the out-of-sample predictions to (1) select a configuration with best performance on a boot-
strapped sample of instances, and (2) score the performance of the selected configuration on the out-of-bootstrap 
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instances only. The returned performance estimate is the average out-of-bootstrap score over all bootstrap 
iterations.
As we repeat each cross-validation 10 times, we used the most robust variant of the protocol — BBC-CV with 
repeats. It includes in the estimate the results from all CV-repeats, which reduces the variance introduced by the 
random partitioning into folds. The number of bootstraps in the protocol was set to 1000.
Recursive feature elimination. To test if a reduced set of features can lead to better performance, we added an 
inner 3-fold cross-validation loop that selects the best subset of features to use in model training. The inner loop 
operates on the training folds only. It starts from a full set of features and eliminates the worst, one by one, until 
only one feature is left. Then a subset of features that maximises inner cross-validation score is selected and used 
to train the model on the full training fold.
Model interpretation. As each tree in the random forest votes for a class label, it is possible to count how many 
times each of the features have contributed to the final decision and estimate the feature importance. The problem 
with the feature importance determined in this way, is that it treats all splits in a tree equally, while the early, close 
to the root splits, tend to have the most impact.
Therefore, we decided not to use the feature importance provided by the random forest, but to examine each 
tree using the TreeExplainer class from the SHAP module25,26. It provides consistent and locally accurate (per 
prediction) estimates of feature influence on the model output. It combines ideas from game theory (Shapley 
sampling values)27 and local explanations (LIME method)28 and goes beyond the impact magnitude, providing 
information on the direction of the influence (probability boost/reduce) in relation to the feature low/high values.
Comparison to the conventional inclusion criteria. To simulate conventional inclusion decisions, we used a logi-
cal conjunction of the following three criteria: (1) a combination of the ACR clinical classification criteria for knee 
OA29, (2) the Kellgren & Lawrence grade of OA severity30,31 between 1 and 3 (inclusive), and (3) pain complaints 
resulting in at least 40 points score on the WOMAC questionnaire. We applied the variant of ACR criteria that 
uses history, physical examination and radiographic findings. It requires presence of (1) pain in the knee and (2) 
one of: age over 50, less than 30 minutes of morning stiffness, crepitus (crackling noises) on active motion and 
osteophytes. We assumed the criteria are satisfied if one of the knees satisfy them.
To simulate selection with machine learning models we used two scenarios: ML-L (based on class labels) and 
ML-P (based on class probabilities). Both scenarios were based on predictions made by the best configuration of 
the duo classifier, specifically the median score model from the median cross-validation repeat.
In the ML-L scenario, we selected all instances classified as progressive (predicted to belong to the P, S, or P + S 
class). This scenario simplifies the task to a binary classification, and makes it comparable to the binary decision 
made using the conventional inclusion criteria.
In the ML-P scenario, for a more direct comparison, we selected the same number of instances as obtained 
with the conventional criteria. We used the progression probabilities p S( ) and p P( ) returned by the model to 
three-way sort the instances (in a descending order) by +p P p S( ) ( ), p S( ), and p P( ). Then we selected 1/3 of 
instances from each sorted group (to obtain balanced representation), in that exact order, disregarding the 
duplicates.
Results
Comparison of algorithms on balanced subsets. In the initial experiments on balanced subsets, the 
best performing algorithm was the random forest. For the CHECK dataset, the other algorithms were competi-
tive only at small training set sizes, and otherwise were trailing 10% and more behind (see Fig. 1a). For the OAI 
dataset, logistic regression and SVC with the RBF kernel were closer, but on the other hand, the performance gap 
between random forest and the linear SVC or multi-modal regression was as large as 20% (see Fig. 1b).
Performance on balanced and imbalanced training set. Figure 2 compares the performance of the 
cost-sensitive and balanced learning. Two observations arise from assessing the trade-off between balanced train-
ing set and potentially easier model training, and imbalanced training set with a larger number of instances to 
train on. Firstly, the bigger training set largely reduced the variance in model performance. Secondly, the typical 
(median) learning curve on the full set had a higher performance at every training set size compared. The differ-
ence was especially large in case of the OAI dataset (about 20% in relative numbers). Therefore, in all subsequent 
experiments we used the full imbalanced training set and the cost-sensitive learning.
Performance of multi-model methods. Figure 3 compares the performance of multi-label and 
multi-model strategies, to a single model 4-class random forest (indicated as “single”). Although all the strategies 
to some degree improved over the single model, the overall performance gain was minor, especially in case of the 
multi-label and one-vs-rest strategies. The duo classifier emerged as the best option, achieving a median F1 score 
improvement of about 2% for CHECK and 1% for OAI. As a result, in subsequent experiments we used the duo 
classifier.
Random forest parameter tuning. Figures 4 and 5 show the typical performance of the duo classifier for 
different algorithm configurations. Each figure reports the F1 score of the median run from the median CV-repeat. 
The best performing configurations for CHECK were located in a sweet spot around 800 trees of maximum depth 
of 9 (for information gain criterion) and depth 8 (for Gini impurity criterion). For OAI, we did not find a clear 
peak spot within the tested range of parameters. The best performing configuration was the one with largest 
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maximum depth of 10 and 400≥  trees. Perhaps configurations allowing for deeper trees could further improve the 
results.
A general conclusion is that above 400 trees the improvement in performance is very small, and a difference in 
the maximum tree depth has the largest impact on the score. However, random forest is not over-training easily 
with more trees, and more trees can be useful (even if they do not improve performance), as they improve the 
reliability of the feature importance estimates. On the other hand, with increased depth and larger trees, their 
interpretability decreases and there is more potential for overfitting.
In subsequent experiments we used the best performing configuration with lowest median absolute devia-
tion, preferring lower depth and less trees in case of ties, in particular: {800 trees, depth 9, entropy criterion} for 
CHECK, and {1000 trees, depth 10, gini criterion} for OAI.
The expected performance (F1 score) of the final models trained on all data, estimated with the Bootstrap Bias 
Corrected Cross-Validation protocol (BBC-CV), was 0.584 — 95% CI (0.560, 0.609) for CHECK, and 0.689 — 
95% CI (0.680, 0.698) for OAI. For both datasets, the estimate is the same (with respect to rounding) as the score 
of a typical run of the best configuration (median of median runs for each CV-repeat).
Figure 1. Learning curves with F1 score for models trained with different algorithms on balanced subsets of the 
dataset. The dotted lines show the total max/min score for each training set size across all subsets and CV-
repeats. The solid lines (one per subset) represent elementwise median of curves for all CV-repeats. The thick 
line is the elementwise median of the 11 median curves shown. The shaded inner area contains all curves plus/
minus their median average deviation (across all CV-repeats), and marks a range of the typical performance. 
For exact numbers and confidence intervals see Suppl. Tables S1 and S2.
Figure 2. Learning curves with F1 score for models trained on the full imbalanced training set (blue) or its 
balanced subsets (green), using the same test set. The dotted lines show the total max/min score for each 
training set size. The solid lines (one per subset) represent elementwise median of curves for all CV-repeats. The 
thick line shows the median score (or elementwise median curve across subsets). The shaded inner area 
represents the median average deviation (across all CV-repeats) around the median curve(s), and marks a range 
of the typical performance.
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Feature selection experiments. Table 3 summarises the results of experiments with the recursive feature 
elimination (RFE) procedure. As the table shows, the use of reduced set of features did not improve the model 
performance. Its median score was about 2% lower compared to configurations using all features. We counted the 
frequency with which each feature was selected (out of 100 selection rounds = 10 repeats * 10 folds). For CHECK 
only minimum JSW (left/right knee), WOMAC pain, WOMAC function, WOMAC total and height of the medial 
eminence (left/right) were selected 100% of the time (see Suppl. Figure S1). For OAI this subset was much larger, 
181 features were selected every time, and overlapped with CHECK features (except eminence which was not 
measured in OAI), therefore not much can be learned there.
The main advantage of a smaller model (using a subset of features) is an easier interpretation, particularly with 
a substantial reduction to a median of just 12 features for CHECK (see Suppl. Figure S2). It is also an advantage 
from the clinical perspective, as data collection is costly and sometimes less measurements could be preferred 
over slightly better performance. However, it would not help much in case of the OAI models, where the median 
number of selected features was almost 20 times higher (see Suppl. Figure S3).
Figure 3. Learning curves with F1 score for multi-model/multi-label methods trained on imbalanced dataset. 
The dotted lines show the total max/min score across all CV-repeats for each training set size. The thick solid 
line shows the median score. The shaded area marks the median average deviation (across all CV-repeats) and 
contains 50%≥  of scores. For exact numbers and confidence intervals see Suppl. Tables S3 and S4.
Figure 4. Performance of different configurations of the duo classifier on the CHECK dataset.
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Model interpretation. Although the best learning strategy was to use all features, it does not mean that 
they all had the same impact. Figures 6 and 7 show features impact on the output of the final model trained on 
the entire CHECK dataset (see Suppl. Table S5a for feature description). For the P sub-predictor, the four most 
impactful features are the WOMAC scores (3 sub-scores and the total score). They all reduce the probability of 
assigning the P label if their value is low and boost that probability if their value is high (see left panel of Fig. 6). 
An example of an opposite direction of influence can be seen for the rfys feature (physical functioning from the 
SF-36 health survey), where higher values indicate a better health status.
For the S sub-predictor, the most impactful features are all related to structural degradation of the knee car-
tilage: the minimum JSW for both knees, with size of the osteophytes in medial tibia region and the varus angle 
(degree of outward bowing at the knee) further down. Low values of minimum JSW reduce the probability of 
assigning the S label. High values of minimum JSW, presence of large osteophytes and deviation in varus angle in 
range [−2.5, 0.5] boost the probability.
Figures 8 and 9 show the impact of features on the output of the final model trained on OAI dataset (see 
Suppl. Table S5b for feature description). For the P sub-predictor, the most impactful features are the KOOS and 
WOMAC pain scores for the left and right knee.
For the S sub-predictor, some of the most impactful features are pain related: DIRKN6 — pain level while 
walking in the last 7 days (part of the WOMAC questionnaire), and P7RKACV — knee pain severity in the last 7 
days. But there are several impactful radiographic features as well, such as: JSW175 — medial JSW at x mm0 175= . , 
MCAJSW — average medial JSW, or MCMJSW — the minimum medial JSW. In the top 3, we can also find 
GLCFQCV — glucosamine frequency of use in past 6 months (glucosamine is a popular supplement used by OA 
patients).
A few features in the top make much less sense: KIKBALL — leg used to kick a ball, or DFUCOLL — difference 
in minutes between baseline and follow-up urine collection times, or IMPIXSZ — radiograph pixel size used in 
conversion to millimetres. This might be a sign of attribute exploitation, as with large number of attributes in OAI 
and not so many instances, the model might be finding dataset specific patterns, rather than discovering general 
rules, and perhaps these attributes should be removed from the dataset. Nevertheless, even if taken alone the con-
tribution of a feature is difficult to explain, it might be useful in interaction with other features, e.g. KIKBALL_3.0 
indicates a person is ambipedal (has no dominant leg), which might trigger the use of radiographic features from 
both knees.
Simulated patient selection. We performed a selection from both datasets using the conventional clinical 
criteria, and compared that to two selection scenarios based on predictions of the best machine learning models: 
ML-L using the class labels, and ML-P using the class probabilities. In the simpler ML-L scenario, we selected all 
Figure 5. Performance of different configurations of the duo classifier on the OAI dataset.
dataset features
F1 score
median 95% CI
CHECK
379 (all) 0.584 (0.583, 0.586)
10–15 (subset) 0.573 (0.570, 0.575)
OAI
1299 (all) 0.69 (0.689, 0.690)
209–364 (subset) 0.676 (0.675, 0.676)
Table 3. Performance of the best model using all features vs. a subset of features found with the RFE procedure. 
We report the median model score for a median CV-repeat and the 95% confidence interval around it (from 
binomial distribution). For the size of the selected subset of features, we report a range across all CV-repeats.
9Scientific RepoRtS |         (2020) 10:8427  | https://doi.org/10.1038/s41598-020-64643-8
www.nature.com/scientificreportswww.nature.com/scientificreports/
instances predicted not to be in the non-progressive class (N). In the more refined ML-P scenario, we selected 
equal number of instances most likely to be in the P + S, S or P class.
Tables 4 and 5 summarise results of the selection with the conventional criteria and the ML-L selection sce-
nario. The comparison between the two revealed several issues with the conventional criteria. Firstly, the retrieval 
of progressive periods was low (18% in total) for both CHECK and OAI, especially in the S category (only 7%). 
Secondly, the selection focused primarily on the P category, resulting in approximately half of the progressive 
periods from there. On the other hand, as desired, the percentage of retrieved non-progressive periods was low 
(5% for CHECK and 7% for OAI).
The ML-L selection scenario retrieved over 2 times more progressive periods ( 45%≈  in total). In the S cate-
gory the retrieval was 5 times higher than the conventional criteria result. The balance between the categories has 
Figure 6. Features impact on P sub-predictor output for CHECK dataset. In the left panel, we show the 
distribution of the impact of a feature value on the model output across all instances. A positive SHAP value 
indicates a positive impact (probability boost). The colour represents the feature value (blue if low, red if high). 
In the right panel, we show the average impact magnitude for all instances. Features in both panels are ordered 
by their total impact.
Figure 7. Features impact on S sub-predictor output for CHECK dataset. In the left panel, we show the 
distribution of the impact of a feature value on the model output across all instances. A positive SHAP value 
indicates a positive impact (probability boost). The colour represents the feature value (blue if low, red if high). 
In the right panel, we show the average impact magnitude for all instances. Features in both panels are ordered 
by their total impact.
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improved for CHECK where P and S categories only differed by 2 p.p., but not for OAI, where the S category 
became dominant. Overall, we see that our machine learning models were less conservative (i.e. have made more 
non-N predictions) than the conventional criteria, which resulted in retrieving more progressive instances, at the 
cost of incorporating higher relative percentage of non-progressive ones.
Although in the ML-L scenario, the machine learning had some advantages in recall levels over the conven-
tional criteria, it selected a larger number of non-progressive instances. It also selected 2.5–3 times more instances 
overall. To make a more direct comparison, in the ML-P scenario we selected the same total number of instances 
as obtained with the conventional criteria. The selection prioritised the instances more likely to progress and 
directly used the probabilities provided by the classifier.
Figure 8. Features impact on P model output for OAI dataset. In the left panel, we show the distribution of the 
impact of a feature value on the model output across all instances. A positive SHAP value indicates a positive 
impact (probability boost). The colour represents the feature value (blue if low, red if high). In the right panel, 
we show the average impact magnitude for all instances. Features in both panels are ordered by their total 
impact.
Figure 9. Features impact on S model output for OAI dataset. In the left panel, we show the distribution of the 
impact of a feature value on the model output across all instances. A positive SHAP value indicates a positive 
impact (probability boost). The colour represents the feature value (blue if low, red if high). In the right panel, 
we show the average impact magnitude for all instances. Features in both panels are ordered by their total 
impact.
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Table 6 shows the results of the ML-P selection scenario. Not only did it reduce the number of non-progressive 
instances compared to the conventional criteria (by 20%≈  for CHECK and ≈25% for OAI), but it also increased 
the balance between the progressive categories (boosting selection from S and P + S, while reducing the bias 
towards P).
Discussion
We hypothesised that machine learning models predicting OA progression could be used to select fast progress-
ing patients more effectively than the conventional inclusion criteria. In a search for the most performant learning 
process configuration, we used a careful evaluation focused on the median performance. For statistical stability 
of the results, we used repeated cross-validation and trained multiple models for each fold using different ran-
dom seeds. We found random forest to stand out as the best learning algorithm. The cost-sensitive learning with 
random forest outperformed the balanced learning on down-sampled training set, and reduced the variance in 
model scores. The multi-model approach with the duo classifier further improved the results. Contrary to our 
expectations, we did not obtain better models with recursive feature elimination.
When predictions of the best models were used to simulate patient selection, we observed a substantial 
reduction in the number of undesired non-progressive cases. This findings could impact the future clinical trials 
design, and potentially improve their efficiency. A machine learning model similar to ours, could be applied to the 
screening data during the inclusion phase of a trial, and suggest which patients should be enrolled in the study. 
The screening visits could be continued until the trial is sufficiently enriched with patients who are likely to show 
disease progression within the trial period, and allow for more effective treatment evaluation.
Limitations and future work. A clear limitation of the experiment design, was the weak preprocessing 
strategy for the OAI dataset. We did not identify the ordinal attributes and therefore we applied one-hot encoding 
to every categorical attribute regardless of its semantics. A similar problem repeated for the continuous attrib-
utes with low number of unique values, which were treated as categorical and unnecessarily encoded. This led 
to a construction of less general decision trees, with splits relying on specific attribute values (rather than value 
ranges), and made the model less trustworthy from a clinical point of view.
A related issue is the clinical relevance of the features the models relied on. It is inevitable that some of the 
features will be exploited to make shortcut decisions, despite not representing any real knowledge. For that rea-
son, it is important to look “inside” the models and iteratively refine the data representation in the training set, to 
gradually eliminate the potential for misuse. But this process is not trivial, as models can use hard to explain fea-
tures (indirectly associated with progression) as a proxy for what is not directly observed. Although we eliminated 
selection
N(1704) P(358) S(579) P+S(160) not N
abs rel recall abs rel recall abs rel recall abs rel recall recall
conventional 88 31% 5% 103 37% 29% 40 14% 7% 49 18% 31% 18%
ML–L 296 38% 17% 183 24% 51% 203 26% 35% 96 12% 60% 44%
Table 4. Subset of CHECK periods selected by the conventional clinical criteria and the ML-L scenario. The 
number of total instances of each category is reported next to the class name. For each category we report 
an absolute and relative number of included instances, and a recall percentage (how many instances of that 
category have been retrieved). The “not N” column shows the summarised recall percentage for all progressive 
instances.
selection
N(12489) P(951) S(2718) P+S(626) not N
abs rel recall abs rel recall abs rel recall abs rel recall recall
conventional 858 52% 7% 366 22% 38% 187 11% 7% 229 14% 37% 18%
ML–L 2254 53% 18% 521 12% 55% 1059 25% 39% 385 9% 62% 46%
Table 5. Subset of OAI periods selected by the conventional clinical criteria and the ML-L scenario. The 
number of total instances of each category is reported next to the class name. For each category we report 
an absolute and relative number of included instances, and a recall percentage (how many instances of that 
category have been retrieved). The “not N” column shows the summarised recall percentage for all progressive 
instances.
dataset selection N P S P + S
CHECK
conventional 31.4% 36.8% 14.3% 17.5%
ML-P 25.4% 28.2% 22.5% 23.6%
OAI
conventional 52.3% 22.3% 11.3% 14.0%
ML-P 38.5% 21.6% 22.3% 17.5%
Table 6. Comparison between selection with conventional clinical criteria and the ML-P scenario.
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some of the feature misuse already (e.g. our first OAI models were misusing the image barcodes), still more work 
needs to be done in this regard, involving further dialogue with the domain experts.
In terms of further improvement of the model performance, it might be possible to achieve better results if the 
configuration of parameters used to train the duo classifier is not shared between its sub-classifiers. That is, each of 
the sub-classifiers could have been tuned separately, including a dedicated feature elimination procedure (perhaps 
even with more inner cross-validation folds), to maximise its individual performance. Whether that would lead 
to a better overall performance is a matter of experiment, as it might as well increase the risk of over-training. 
For certain, it would require a substantial additional computational effort — the longest RFE experiment we 
performed so far, already took over 200 CPU days on our HPC cluster (using Intel Xeon E5-2690 processor). 
Moreover, due to the sequential nature of the RFE procedure (features were eliminated one by one), it cannot be 
easily sped up through parallelisation.
Another question is, how easy would it be to implement our approach in clinical practice. The main obstacle 
would be the process of patients’ data collection. It is usually performed on a rolling basis (over the course of 
several months), due to logistics reasons (e.g. limited access to equipment or personnel), which makes a single 
selection step, as we performed in this work, impractical. Therefore, further work is needed on extending this 
approach towards a multi-step selection, in which decisions are made on small batches of patients as their data 
become available, without sacrificing the overall selection quality.
Choice of performance measure. In this work, inspired by the similarity of the patient selection problem 
to the task of document retrieval, we decided to measure the classification performance with F1 score. Below, we 
briefly discuss the advantages and drawbacks of several alternative measures.
Area under the ROC curve (AUC) is commonly used in medical binary classification tasks such as cases vs. 
controls analysis. Although a generalisation to multi-class problems, M-score, has been proposed by Hand and 
Till32, the use of AUC for model comparison has been strongly criticised by Hand himself. He not only pointed 
out problems with comparison of the crossing ROC curves (where difference in AUC creates false impression 
that one curve dominates the other), but also demonstrated the measure incoherence33 (AUC evaluates different 
classifiers with a different metric, as it depends on the score distributions, which depend on the classifier). Hand 
proposed H-measure as a replacement for the AUC, but it has been only defined for binary classification.
Matthew’s Correlation Coefficient (MCC) is another measure of binary classification performance34 that has 
been extended to handle multi-class problems35. Its main merit is in taking into account true negatives (accuracy 
or F1 do not), which makes MCC especially useful when negative examples are the minority. Unfortunately, this is 
not the case in the patient selection task.
Measures based on the error matrix (like F1 score or MCC), do not take into account the distance in the class 
probability space (they treat every mistake the same, regardless of its scale). There are several measures that do, 
but they lack in other aspects. For example, area under the precision-recall curve (AUPRC) does not generalise to 
a multi-class case. Log-loss or the Brier distance can handle multi-class problems, but they do not address the 
class imbalance directly. Perhaps the patient selection task would benefit from a dedicated measure of perfor-
mance designed to align with the specific recruitment requirements.
Related work. Although several long-term OA clinical studies have been completed and their outcomes 
analysed in detail, very little research has been done on improving the patient selection process. To our best 
knowledge, this work is a first attempt at building machine learning models that can compete with the established 
clinical practice.
Our approach differs from most of the analyses found in the literature in two important ways. Firstly, it does 
not focus on determining the risk factors, but on the prediction of the disease progression. Secondly, it defines 
the progression within a strict time window and targets the change in fine-grained radiographic measurements 
(JSW), rather than just a categorical difference in the KL/JSN grade.
Most of the previous works do not focus on disease progression, but analyse OA incidence instead, where a 
patient can either be diagnosed with OA (typically when KL grade 2≥ ) or be “OA free” (when KL grade 1≤ ). The 
incidence of disease is then defined, as a change in diagnosis of the same knee between the baseline and the 
follow-up visit, and is analysed with statistical methods to determine the risk factors (usually odds ratios with 
univariate analysis of variance, or multivariate logistic regression). Some authors go a bit further and test the 
logistic regression models on a binary classification task (cases vs. controls)36–38 hand-picking the input variables. 
However, as Jamshidi et al. point out in their recent perspective article39, very few authors reach beyond statistical 
analysis and build machine learning models.
Yoo et al.40 trained an artificial neural network with 7 inputs and 3 hidden layers to directly predict the KL 
grade, obtaining AUC 0 8> . . However, they only focused on discriminating between KL grade levels at baseline, 
rather than trying to predict future disease progression. Similar results were obtained with random forest by 
Minciullo et al.41 who were able to discriminate between cases and controls with AUC 0 85> . , but in the prediction 
task (same cohort, OA incidence after 84 months) achieved a much lower score (≈ .0 6). Better OA incidence pre-
diction (AUC > .0 8) was reported by Lazzarini et al.42 who used random forest with an iterative feature elimina-
tion heuristic (RGIFE).
These results are not directly comparable, as the models were trained on data from different cohorts. As a 
consequence, the models operated on a different input, and used inconsistent definition of the outcome (the OA 
incidence was defined over a period of varying length: 1038, 741, or 2.542 years). Moreover, due to the AUC measure 
incoherence discussed earlier, any comparison between these models would be, at most, approximate.
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When it comes to the definition of the progression used in this article, in many aspects it is similar to the defi-
nition used by the FNIH OA Biomarkers Consortium (e.g.7,43). They likewise defined four categories of patients 
(N, P, S, and P + S) based on the change in WOMAC/JSW over time, but flexibly allowed the progression to 
happen at 2, 3 or 4 year follow-up. In contrast to our fixed 2 year time period, this does not select for a fast pro-
gression. Furthermore, the analysis performed in these works, is again focused on the risk factors only. In the 
best case, a test of discriminatory power is performed (without correcting for overfitting) but no independent 
prediction is attempted. Notable exception is the work by Hafezi-Nejad et al.44. who used a small artificial neural 
network with 10 inputs and 1 hidden layer to predict the joint space loss, and with a single training/test set ran-
dom split and 100 runs, obtained an average AUC of 0.669.
Conclusions
The aim of this work has been to test if the machine learning models can be more predictive of the future knee OA 
progression than the conventional clinical selection criteria. We focused on a short progression time window typ-
ical for clinical trials. Using data from two long-term knee OA studies (CHECK and OAI), we experimented with 
different learning strategies to build the final models, and obtained the best results with a custom-made duo clas-
sifer. The model-based selection, compared to the conventional criteria, resulted in 20–25% less non-progressive 
cases and more balanced retrieval of progressive cases.
These results put into question the effectiveness of the conventional selection criteria, which although straight-
forward to apply in practice, were found to be less predictive of the future disease progression. At the same time, 
these results reveal a potential to develop more precise screening tools, leading to better designed clinical trials, 
and in consequence, to more successful evaluation of therapies, which is important for patients, scientific com-
munity, pharmaceutical industry and the ageing society in general.
Further work is needed before this potential is fully understood. Our approach needs to be implemented into 
the clinical practice, and tested in a real study. That involves a number of challenges, from methodology of the 
model evaluation to logistics of the selection process. We hope to solve some of them in the APPROACH study 
recruitment process, and based on its future results, assess the practical impact of the model-based selection.
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